Mallapur, India

Joshodeep Boruwa

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Joshodeep Boruwa

Introduction

Joshodeep Boruwa is an accomplished inventor based in Mallapur, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel therapeutic agents. His work focuses on addressing various health conditions associated with cortisol production.

Latest Patents

Joshodeep Boruwa holds a patent for "Cytochrome P450 inhibitors and their method of use." This invention relates to innovative cytochrome P450 inhibitors and pharmaceutical compositions that exhibit disease-modifying actions. These compositions are aimed at treating diseases linked to cortisol production, including metabolic syndrome, obesity, headache, depression, hypertension, diabetes mellitus, Cushing's Syndrome, pseudo-Cushing syndrome, cognitive impairment, dementia, heart failure, renal failure, psoriasis, glaucoma, cardiovascular disease, cancer, stroke, and incidentalomas.

Career Highlights

Currently, Joshodeep Boruwa is associated with Cortendo AB, a company dedicated to advancing treatments for endocrine disorders. His expertise in pharmacology and drug development has positioned him as a key figure in his field. His innovative approach to addressing complex health issues has garnered attention and respect within the scientific community.

Collaborations

Joshodeep has collaborated with notable professionals in his field, including Benjamin E Blass and Magid A Abou-Gharbia. These partnerships have facilitated the exchange of ideas and have contributed to the advancement of research in pharmaceutical sciences.

Conclusion

Joshodeep Boruwa's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving health outcomes. His work continues to pave the way for new treatments that address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…